BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15005634)

  • 1. Exosite occupation by heparin enhances the reactivity of blood coagulation factor IXa.
    Neuenschwander PF
    Biochemistry; 2004 Mar; 43(10):2978-86. PubMed ID: 15005634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding.
    Schmidt AE; Stewart JE; Mathur A; Krishnaswamy S; Bajaj SP
    J Mol Biol; 2005 Jul; 350(1):78-91. PubMed ID: 15913649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXa.
    Sheehan JP; Kobbervig CE; Kirkpatrick HM
    Biochemistry; 2003 Sep; 42(38):11316-25. PubMed ID: 14503882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase.
    Jenkins PV; Dill JL; Zhou Q; Fay PJ
    Biochemistry; 2004 May; 43(17):5094-101. PubMed ID: 15109268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.
    Yuan QP; Walke EN; Sheehan JP
    Biochemistry; 2005 Mar; 44(9):3615-25. PubMed ID: 15736971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin modulates the 99-loop of factor IXa: effects on reactivity with isolated Kunitz-type inhibitor domains.
    Neuenschwander PF; Williamson SR; Nalian A; Baker-Deadmond KJ
    J Biol Chem; 2006 Aug; 281(32):23066-74. PubMed ID: 16766524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The second epidermal growth factor-like domain of human factor IXa mediates factor IXa binding to platelets and assembly of the factor X activating complex.
    Wong MY; Gurr JA; Walsh PN
    Biochemistry; 1999 Jul; 38(28):8948-60. PubMed ID: 10413468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenesis studies toward understanding the mechanism of differential reactivity of factor Xa with the native and heparin-activated antithrombin.
    Rezaie AR; Yang L; Manithody C
    Biochemistry; 2004 Mar; 43(10):2898-905. PubMed ID: 15005625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of sodium ion binding on factor IXa activity.
    Gopalakrishna K; Rezaie AR
    Thromb Haemost; 2006 Jun; 95(6):936-41. PubMed ID: 16732371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan.
    Mauray S; de Raucourt E; Talbot JC; Dachary-Prigent J; Jozefowicz M; Fischer AM
    Biochim Biophys Acta; 1998 Sep; 1387(1-2):184-94. PubMed ID: 9748565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis.
    Plautz WE; Sekhar Pilli VS; Cooley BC; Chattopadhyay R; Westmark PR; Getz T; Paul D; Bergmeier W; Sheehan JP; Majumder R
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):816-828. PubMed ID: 29419409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.
    Johnson DJ; Langdown J; Huntington JA
    Proc Natl Acad Sci U S A; 2010 Jan; 107(2):645-50. PubMed ID: 20080729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin and calcium ions dramatically enhance antithrombin reactivity with factor IXa by generating new interaction exosites.
    Bedsted T; Swanson R; Chuang YJ; Bock PE; Björk I; Olson ST
    Biochemistry; 2003 Jul; 42(27):8143-52. PubMed ID: 12846563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of benzothiophene template as potent factor IXa (FIXa) inhibitors in thrombosis.
    Wang S; Beck R; Blench T; Burd A; Buxton S; Malic M; Ayele T; Shaikh S; Chahwala S; Chander C; Holland R; Merette S; Zhao L; Blackney M; Watts A
    J Med Chem; 2010 Feb; 53(4):1465-72. PubMed ID: 20121198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of inhibition rate enhancement by covalent linkage of antithrombin to heparin as a potential predictor of reaction mechanism.
    Patel S; Berry LR; Chan AK
    J Biochem; 2007 Jan; 141(1):25-35. PubMed ID: 17167048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium-site in serine protease domain of human coagulation factor IXa: evidence from the crystal structure and molecular dynamics simulations study.
    Vadivel K; Schreuder HA; Liesum A; Schmidt AE; Goldsmith G; Bajaj SP
    J Thromb Haemost; 2019 Apr; 17(4):574-584. PubMed ID: 30725510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of the heparin binding exosite of factor IXa.
    Yang L; Manithody C; Rezaie AR
    J Biol Chem; 2002 Dec; 277(52):50756-60. PubMed ID: 12397068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of factor IXa subsite modulations with effects on substrate discrimination.
    Neuenschwander PF; Deadmond KJ; Zepeda K; Rutland J
    J Thromb Haemost; 2012 Mar; 10(3):382-9. PubMed ID: 22212890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The heparin-binding exosite is critical to allosteric activation of factor IXa in the intrinsic tenase complex: the role of arginine 165 and factor X.
    Misenheimer TM; Buyue Y; Sheehan JP
    Biochemistry; 2007 Jul; 46(26):7886-95. PubMed ID: 17563121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa.
    Yang L; Manithody C; Qureshi SH; Rezaie AR
    J Biol Chem; 2010 Sep; 285(37):28488-95. PubMed ID: 20628058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.